Real-time enrollment status for this multiple system atrophy clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:54 AM UTC
| NCT Number | NCT06568237 |
| Recruiting Status | Recruiting |
| Condition | Multiple System Atrophy |
| Phase | PHASE2 |
| Target Enrollment | 350 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of July 19, 2026: Clinical trial NCT06568237 is currently recruiting participants. This phase2 study for multiple system atrophy is actively seeking new participants at 19 locations across the United States. The study is sponsored by Teva Branded Pharmaceutical Products R&D, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06568237 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06568237 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.